trial · primary record
adjuvant treatment
Esophageal Squamous Cell Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 145 |
| Primary completion | 2025-03-10 |
| Primary endpoint | Overall Survival |
| Registry ID | NCT04009265 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:32.902Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04009265
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.